Zhou, Hang http://orcid.org/0000-0002-7694-6391
Cheng, Zhongshan
Bass, Nicholas
Krystal, John H.
Farrer, Lindsay A.
Kranzler, Henry R. http://orcid.org/0000-0002-1018-0450
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Funding for this research was provided by:
VA Connecticut Healthcare Center
National Center for Post Traumatic Stress Disorder
Philadelphia VA MIRECCS
Article History
Received: 11 December 2017
Revised: 21 February 2018
Accepted: 11 May 2018
First Online: 4 October 2018
Conflict of interest
: Dr. Kranzler has been a consultant or advisory board member for Indivior and Lundbeck. He is also a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which was supported for the last 3 years by AbbVie, Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, Pfizer, Arbor, and Amygdala Neurosciences. Dr. Krystal has stock in ArRETT Neuroscience and Biohaven Pharmaceuticals Medical Sciences, and has stock options in Biohaven Pharmaceuticals Medical Sciences, Blackthorn Therapeutics, and Luc Therapeutics. Dr. Krystal also has patents and inventions 5,447,948, 8,778,979 B2, 14/197,767, 14/306,382, 61/973,961, Y0087.70116US00, and 62/444,552. The other authors have no biomedical financial interests or potential conflicts of interest.